| Literature DB >> 28608458 |
S Heleen Binnenmars1, R S Hijmans1, G Navis1, M H de Borst1.
Abstract
This review provides an overview of the clinical value of the most relevant renal biomarkers, focusing on two main clinical conditions: acute kidney injury and chronic kidney disease. We categorize biomarkers according to their actionability, in terms of a documented response to treatment in relation to outcomes. Furthermore, we introduce a new category of renal biomarkers, metabolic biomarkers, and underscore their capacity to be highly actionable.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28608458 DOI: 10.1002/cpt.765
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875